Adamas Announces New Employment Inducement Grant
November 13, 2020 16:05 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three...
Adamas Reports Third Quarter 2020 Financial Results
November 05, 2020 16:03 ET
|
Adamas Pharmaceuticals, Inc.
Third quarter 2020 total revenues of $20.2 million, a 45% increase over third quarter 2019 Third quarter 2020 GOCOVRI® product sales of $19.0 million, a 36% increase over third quarter 2019...
Adamas announces settlement agreement of previously disclosed class action litigation
November 02, 2020 09:25 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020
October 26, 2020 16:04 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2020 third quarter financial results on Thursday,...
Adamas Announces New Employment Inducement Grant
October 09, 2020 16:03 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new...
Adamas appoints new Chief Medical Officer, Adrian Quartel, MD
October 01, 2020 09:15 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas Announces New Employment Inducement Grant
September 11, 2020 16:04 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted two new...
Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinson’s disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress
September 11, 2020 09:15 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas to Present at Upcoming HC Wainwright Conference
September 08, 2020 16:05 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas Appoints Anna Richo to Board of Directors
September 01, 2020 09:15 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...